UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Award Lecture Evolution of long-term adjuvant anti-hormone therapy: Consequences and opportunities

Breast (Edinburgh), 2011, Vol.20, p.S1-S1

Jordan, V.C

2011

Volltextzugriff (PDF)

S29 Optimizing treatment and prevention of breast cancer: Time for a change?

Breast (Edinburgh), 2007, Vol.16, p.S9-S9

Jordan, V.C

2007

Volltextzugriff (PDF)

Results of the CONFIRM Phase III Trial Comparing Fulvestrant 250mg With Fulvestrant 500mg in Postmenopausal Women With Estrogen Receptor–Positive Advanced Breast Cancer

Breast diseases, 2012-01, Vol.23 (2), p.190-191

Jordan, V.C.

2012

Volltextzugriff (PDF)

Impact of Raloxifene or Tamoxifen Use on Endometrial Cancer Risk: A Population-Based Case-Control Study

Breast diseases, 2009-01, Vol.20 (1), p.95-96

Jordan, V.C.

2009

Volltextzugriff (PDF)

S37 Endocrine Therapies in the Future: Will an Old Dog Learn New Tricks?

Breast (Edinburgh), 2005-02, Vol.14, p.S14-S14

Jordan, V.C.

2005

Volltextzugriff (PDF)

2–39 Continuing Outcomes Relevant to Evista: Breast Cancer Incidence in Postmenopausal Osteoporotic Women in a Randomized Trial of Raloxifene

Breast diseases, 2005-07, Vol.16 (2), p.183

Jordan, V.C.

2005

Volltextzugriff (PDF)

S26 The molecular biology of the estrogen receptor (ER) aids in the understanding of tamoxifen resistance and breast cancer prevention with raloxifene

European journal of cancer (1990), 1998-02, Vol.34, p.S6-S7

Jordan, V.C.

1998

Volltextzugriff (PDF)

O-097. Action of oestrogens and their antagonists on target organs

Human reproduction (Oxford), 1997-06, Vol.12 (Suppl_2), p.46-46

Jordan, V.C.

1997

Volltextzugriff (PDF)

Subcellular compartmentalization of MCF-7 estrogen receptor synthesis and degradation

Molecular and cellular endocrinology, 1993-08, Vol.94 (2), p.183-194

1993

Volltextzugriff (PDF)

Selective oestrogen receptor modulation

European journal of cancer (1990), 1999-12, Vol.35 (14), p.1974-1985

1999

Volltextzugriff (PDF)

Selective oestrogen receptor modulation

European journal of cancer (1990), 1999-11, Vol.35 (12), p.1628-1639

1999

Volltextzugriff (PDF)

What if tamoxifen (ICI 46,474) had been found to produce rat liver tumors in 1973?

Annals of oncology, 1995-01, Vol.6 (1), p.29-34

Jordan, V.C.

1995

Volltextzugriff (PDF)

IV.7 Tamoxifen and uterine cancer: Confounding variables

European journal of cancer (1990), 1998, Vol.34, p.S50-S51

Jordan, V.C.

1998

Volltextzugriff (PDF)

Oestrogen receptors, growth factors and the control of breast cancer

Breast (Edinburgh), 2001-08, Vol.10, p.27-35

Jordan, V.C.

2001

Volltextzugriff (PDF)

Oestrogens, Oestrogen Receptors and Breast Cancer

European journal of cancer supplements, 2003-09, Vol.1 (1), p.1-12

2003

Volltextzugriff (PDF)

V.3 Is there life after tamoxifen? New anti-oestrogens

European journal of cancer (1990), 1998, Vol.34, p.S57-S58

1998

Volltextzugriff (PDF)

8.08 - Tamoxifen

Comprehensive Medicinal Chemistry II, 2007, Vol.8, p.83-102

Jordan, V.C.

Second Edition, 2007

Volltextzugriff (PDF)

HEALTH AND SAFETY INSPECTIONS

The Lancet (British edition), 1977-12, Vol.310 (8049), p.1174-1174

Jordan, V.C.

1977

Volltextzugriff (PDF)

Effect of Chronic Administration of Mestranol, Tamoxifen, and Toremifene on Hepatic Ploidy in Rats

Toxicological sciences, 1998-06, Vol.43 (2), p.129-138

1998

Volltextzugriff (PDF)

TAMOXIFEN PROPHYLAXIS

The Lancet (British edition), 1986, Vol.327 (8472), p.105-105

Jordan, V.C.

1986

Volltextzugriff (PDF)

The biological action of cDNAs from mutated estrogen receptors transfected into breast cancer cells

Cancer letters, 1995-03, Vol.90 (1), p.35-42

1995

Volltextzugriff (PDF)

Metabolism of steroid-modifying anticancer agents

Pharmacology & therapeutics (Oxford), 1988, Vol.36 (1), p.41-103

1988

Volltextzugriff (PDF)

A study of the oestrogenic and anti-oestrogenic activities of some substituted triphenylethylenes and triphenylethanes

Jordan, V.C

1972

Volltextzugriff (PDF)

243. Antitumour activity of the antiestrogen ICI 46,474 (Tamoxifen) in the dimethylbenzanthracene (DMBA)—induced rat mammary carcinoma model

Journal of steroid biochemistry, 1974-06, Vol.5 (4), p.354-354

Jordan, V.C.

1974

Volltextzugriff (PDF)

112 Effects of estradiol on components of the plasminogen-plasmin system in MDA-MB-231 breast cancer cells stably transfected with the estrogen receptor

Fibrinolysis & proteolysis, 1997-10, Vol.11, p.32-32

1997

Volltextzugriff (PDF)

1 – 25 von 54

Menü

Weitere Dienste

Einstellungen

Award Lecture Evolution of long-term adjuvant anti-hormone therapy: Consequences and opportunities

S29 Optimizing treatment and prevention of breast cancer: Time for a change?

Results of the CONFIRM Phase III Trial Comparing Fulvestrant 250mg With Fulvestrant 500mg in Postmenopausal Women With Estrogen Receptor–Positive Advanced Breast Cancer

Impact of Raloxifene or Tamoxifen Use on Endometrial Cancer Risk: A Population-Based Case-Control Study

S37 Endocrine Therapies in the Future: Will an Old Dog Learn New Tricks?

2–39 Continuing Outcomes Relevant to Evista: Breast Cancer Incidence in Postmenopausal Osteoporotic Women in a Randomized Trial of Raloxifene

S26 The molecular biology of the estrogen receptor (ER) aids in the understanding of tamoxifen resistance and breast cancer prevention with raloxifene

O-097. Action of oestrogens and their antagonists on target organs

Subcellular compartmentalization of MCF-7 estrogen receptor synthesis and degradation

Selective oestrogen receptor modulation

Selective oestrogen receptor modulation

What if tamoxifen (ICI 46,474) had been found to produce rat liver tumors in 1973?

IV.7 Tamoxifen and uterine cancer: Confounding variables

Oestrogen receptors, growth factors and the control of breast cancer

Oestrogens, Oestrogen Receptors and Breast Cancer

V.3 Is there life after tamoxifen? New anti-oestrogens

8.08 - Tamoxifen

HEALTH AND SAFETY INSPECTIONS

Effect of Chronic Administration of Mestranol, Tamoxifen, and Toremifene on Hepatic Ploidy in Rats

TAMOXIFEN PROPHYLAXIS

The biological action of cDNAs from mutated estrogen receptors transfected into breast cancer cells

Metabolism of steroid-modifying anticancer agents

A study of the oestrogenic and anti-oestrogenic activities of some substituted triphenylethylenes and triphenylethanes

243. Antitumour activity of the antiestrogen ICI 46,474 (Tamoxifen) in the dimethylbenzanthracene (DMBA)—induced rat mammary carcinoma model

112 Effects of estradiol on components of the plasminogen-plasmin system in MDA-MB-231 breast cancer cells stably transfected with the estrogen receptor

Aktive Filter

Suchergebnisse filtern